Bixiye
BC-COM-PharmProgPolicyNotifctn-Eff-7.1.21-FINAL-05212021.pdf
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1891 - 1900 ee natiijooyinka 3563
Bixiye
QP41-21 Commercial and MHCP Pharmacy Benefit Exclusion for Qutenza®
Taariikhda uu dhaqangalayo Barnaamijka: May 12, 2021
Bixiye
QP42-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Agents
Taariikhda uu dhaqangalayo Barnaamijka: May 12, 2021
Bixiye
QP2-21 Update for New to Market Medical Drugs: Aducanumab, Casimersen, Evinacumab, Idecabtagene Vicleucel, and Pegunigalsidase Alfa
Taariikhda uu dhaqangalayo Barnaamijka: Jan 13, 2021
Bixiye
P29-21 Reimbursement Change for Licensed Professional Clinical Counselors (LPCC)
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Bixiye
P21-21 RAP Claims Required for Home Care Claims Effective July 1, 2021
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021
Bixiye
P26-21 Sequestration Suspension for Medicare Lines of Business Extended
Taariikhda uu dhaqangalayo Barnaamijka: May 03, 2021